Clinical Trial Update: Neuromodulation of the Hippocampus to Reduce Intrusive Re-Experiencing in PTSD: A Randomized Controlled Trial [Phase 2]

View source ↗

Summary

Phase 2 randomized trial investigating hippocampal neuromodulation to reduce intrusive re-experiencing symptoms in post-traumatic stress disorder; currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Snippet

Sponsor: Tel Aviv University | Conditions: PTSD - Post Traumatic Stress Disorder, Intrusive Memories of Traumatic Event(s) | Phase 2 | Status: RECRUITING